Tempicol-2 (4-hydroxy-4-(2-picolyl)-2,2,6,6-tetramethylpiperidine-1-oxyl), a stable free radical, is a novel member of nitroxide class of antioxidants and anticancer agents

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 369-377

  Metodiewa, Diana ^a   Skolimowski, Janusz ^b   Kochman, Agata ^c   Gwozdzinski, Krzysztof ^b   Głebska, Jolanta ^a  

^a LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Antioxidants; Apoptosis; Experimental Yoshida Sarcoma; Novel nitroxides; Pharmacological tests

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; FREE RADICAL; IRON; NITROXIDE DERIVATIVE; RUTOXYL; TEMPACE; TEMPICOL 2; UNCLASSIFIED DRUG; XANTHINE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; FEMALE; GAMMA RADIATION; GROWTH INHIBITION; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; RAT; YOSHIDA SARCOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCORBIC ACID; CYCLIC N-OXIDES; DEOXYRIBOSE; FEMALE; FREE RADICALS; MALE; NITROBLUE TETRAZOLIUM; OXIDATION-REDUCTION; PYRIDINES; RADIATION-PROTECTIVE AGENTS; RATS; REACTIVE OXYGEN SPECIES; SARCOMA, EXPERIMENTAL; SUPEROXIDES; TUMOR CELLS, CULTURED;

EID: 0031922160     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Krishna MC and Samuni A: Nitroxides as antioxidants. Meth Enzymol 234: 580-589, 1994.
2. Mitchell JB. DeGraff W, Kaufman D and Krishna MC: Inhibition of oxygen - dependent radiation - induced damage by the nitroxide Superoxide dismutase mimic. Arch Biocher Biophy 289: 62-70, 1991.
3. Johnstone PAS, DeGraff WG and Mitchell JB: Protection from radiation - induced chromosomal aberations by the nitroxide Tempol. Cancer 75: 2323-2327, 1995.
4. Swartz HM: Interactions between cells and nitroxides and their implications for their uses as biophysical probes and metabolically responsive contrast agents for in vivo NMR. Bull Mag Res 8: 172-175, 1986.
5. Swartz HM: Use of nitroxides to measure redox metabolism in cells and tissues. J Chem Soc Faraday Trans 1, 83: 191-202, 1987.
6. Sun Y: Free radicals, antioxidant enzymes and carcinogenesis. Free Rad Biol Med 8: 583-599, 1990.
7. Yu BP: Cellular defences against damage from reactive oxygen species. Physiol Rev 74: 139-162, 1994.
8. Samuni A, Godinger D, Aronovitch J, Russo A and Mitchell JB: Nitroxides block RNA scission and protect cells from oxidative damage. Biochemistry 30: 555-561, 1991.
9. Hahn SM, Tochner Z, Krishna MC, Wilson L, Samuni A, Venzon D, Glatstein E, Mitchell JB and Russo A: Tempol a stable free radical is a novel, murine radioprotector. Cancer Res 52: 1750-1753, 1992.
10. Nilsson US, Olsson IJ, Garlin G and Bylund FA: Inhibition of lipid peroxidation by spin labels. Relationship between structure and function. J Biol Chem 264: 11131-11135, 1989.
11. Morris S, Sosnovsky G, Hui B, Huber CO, Rao NO and Swartz HM: Chemical and electrochemical reduction rates of cyclic nitroxides. J Pharm Sci 80: 149-152, 1991.
12. Winkler BS, Orselli SM and Rex TS: The redox couple between glutathione and ascorbic acid. A chemical and physiological perspective. Free Rad Biol Med 17: 333-349, 1994.
13. Samuni A, Mitchell JB, DeGraff W, Krishna MC, Samuni U and Russo A: Nitroxide SOD mimics: modeofaction. Free Rad Res Commun 12-13: 187-194, 1991.
14. Krishna MC, Graham DA, Samuni A, Mitchell JB and Russo A: Oxoammonium cation intermediate in the nitroxide catalyzed dismutation of nitroxide. Proc Natl Acad Sci USA 89: 5537-5541, 1992.
15. Gonzales MJ and Riordan NH: The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary. Med Hypotheses 46: 503-504, 1996.
16. Bozzi A, Mavelli J, Mondovi B, Strom R and Rotilio G: Differential cytotoxicity of daunomycin in tumor cells is related to glutathione -dependent hydrogen peroxide metabolism. Biochem J 194: 369-372, 1981.
17. Hahn SM, Krishna MC, Liebmann J, DeGraffW, Gamson J, Samuni A, Venzon D and Mitchell JB: Identification of nitroxide radioprotectors. Radiation Res 132: 87-93, 1992.
18. Rachmilevitz D, Karmeli F, Okon E and Samuni A: A novel antiulcerogenic stable radical prevents gastric mucosal lesions in rats. Gut 35: 1181-1188, 1994.
19. Metodiewa D, Skolimowski J, Kochman A and Karolczak S: Rutoxyl [rutin/4-acetamide-1-hydroxy-2,2,6,6-tetramethylpiperidinium] is a new member of the class of seminatural products of high pharmacological potency. Biochem Mol Biol Intern 42: 1261-1270, 1997.
20. Hendrix M, Alper PB, Prestley ES and Wong C-H: Hydroxylamine as a new motif for the molecular recognition of phosphodiesters: implications for aminoglycoside - RNA interactions. Angew. Chemie 36: 95-98, 1997.
21. Okada S: Iron-induced tissue damage and cancer: the role of reactive oxygen species - free radicals. Pathol Intern 46: 311-332, 1996.
22. Yoshida T: Studies on an ascites (reticuloendothelial cell) sarcoma of the rat. J Natl Cancer Inst (Japan) 12: 947-968, 1951.
23. Metodiewa D. Skolimowski J and Karolczak S: Tempace and Troxylnovel synthesised 2,26,6-tetramethylpiperidine derivatives as antioxidants and radioprotectors. Biochem Mol Biol Intern 40: 1211-1219, 1996.
24. Olszak TA, Grabowski MJ and Gwozdzinski K: Piperidine nitroxide radicals with heterocyclic ring substituents. I. Structure of 4-hydroxy-2,2,6,6-tetramethyl-4-(2-pyridylmethyl)piperidine-1-oxide. Acta Cryst C49: 1722-1723, 1993.
25. Aruoma OJ: Deoxyribose assay for detecting hydroxyl radicals. Meth. Enzymol 233: 57-66, 1994.
26. Winterbourn CC: Factors that influence the deoxyribose oxidation assay for Fenton reaction products. Free Rad Biol Med 11: 353-360, 1991.
27. Franzini E, Sellak H, Hakim J and Pasquier C: Comparative sugar degradation by (OH) produced by the iron-driven Fenton reaction and gamma radiolysis. Arch Biochem Biophys 309: 261-265, 1994.
28. Skolimowski J, Metodiewa D, Kochman A, Ru}ka J and Gwozdzinski K: Novel complex Rutoxyl as antioxidant and radioprotector. Free Radical Research (submitted), 1997.
29. Anderson RF, Patal KB, Regneby K and Hill SA: Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumor and normal tissue. Br J Cancer 60: 193-197, 1989.
30. Buxton GV, Greenstock CL, Helma WP and Ross AB: Reactivity of OH radicals in aqueous solutions. J Phys Chem Ref Data 17: 513-750, 1988.
31. Sosnovski G and Paul BD: In the search for new anticancer drugs. 9. Synthesis and anticancer activity of spin-labeled analogues of Thio-Tepa. J. Med. Chem. 27: 782-788, 1984.
32. Bjornsson TD: A classification of drug action based on therapeutic effects. J Clin Pharmacol 36: 669-673, 1996.
33. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metast. Rev 11: 121-129, 1992.
34. Buttke TM and Sandstrom PA: Oxidative stress as a mediator of apoptosis. Immunol. Today 15: 7-10, 1994.
35. Cerutti PA: The role of active oxygen in tumor promotion. In: Biochemistry and molecular epidemiology of cancer (Harris CC, ed.) NY: Alan R. Liss Inc. 1986, 167-176.
36. Metodiewa D. and Dunford HB: Medical aspects and techniques for peroxidases and catalases. In: Atmospheric oxidation and antioxidants (Scott G. ed.). Elsevier, Amsterdam, 1993, 287-332.
37. Gardner AM, Xu F-H, Fady C, Jacoby FJ, Duffey DC, TuY and Lichtenstein A: Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Rad Biol Med 22: 73-83, 1997.
38. Halliwell B: Commentary. Antioxidant characterization, methodology and mechanism. Biochem Pharmacol 49: 1341-1348, 1995.